Leukemia and Lymphoma Misdiagnosis in New York

Understanding Leukemia

Leukemia is cancer of the blood-forming tissues, including the bone marrow. It results in the overproduction of abnormal white blood cells. The main types of leukemia include:

• Acute myeloid leukemia (AML): The most common type of acute leukemia in adults. AML progresses rapidly and requires immediate treatment. Symptoms include fatigue, fever, easy bruising/bleeding, and frequent infections.
• Acute lymphoblastic leukemia (ALL): The most common type of leukemia in children, but also occurs in adults. ALL progresses rapidly and requires immediate treatment.
• Chronic lymphocytic leukemia (CLL): The most common type of chronic leukemia in adults. CLL progresses slowly and may not require immediate treatment, but requires monitoring.
• Chronic myeloid leukemia (CML): A slowly progressing leukemia associated with the Philadelphia chromosome. CML is treated with targeted therapy (tyrosine kinase inhibitors).

Understanding Lymphoma

Lymphoma is cancer of the lymphatic system, which includes lymph nodes, the spleen, and other lymphoid tissues. The main types include:

• Hodgkin lymphoma: Characterized by the presence of Reed-Sternberg cells. Hodgkin lymphoma is highly treatable, with a 5-year survival rate of 89%.
• Non-Hodgkin lymphoma (NHL): A diverse group of lymphomas. The 5-year survival rate varies widely depending on the subtype, ranging from 60% to 90% for indolent (slow-growing) subtypes to 30-60% for aggressive subtypes.

How Leukemia and Lymphoma Are Diagnosed

Diagnosis of blood cancers involves specialized testing:

• Complete blood count (CBC) with differential: The first step in diagnosing leukemia. CBC detects abnormal numbers of white blood cells, red blood cells, and platelets. An elevated white blood cell count with abnormal cells (blasts) is concerning for leukemia.
• Peripheral blood smear: A drop of blood is examined under a microscope to evaluate the appearance of blood cells. Blasts (immature cells) or abnormal lymphocytes suggest leukemia or lymphoma.
• Flow cytometry: A specialized test that identifies specific markers on the surface of blood cells. Flow cytometry is critical for diagnosing and classifying leukemia and lymphoma.
• Bone marrow biopsy: A sample of bone marrow is obtained (typically from the hip bone) and examined under a microscope. Bone marrow biopsy is essential for diagnosing leukemia and some lymphomas.
• Lymph node biopsy: For lymphoma, an enlarged lymph node is biopsied and examined by a pathologist. Excisional biopsy (removing the entire lymph node) is preferred over needle biopsy.
• Pathology: The pathologist (specifically a hematopathologist) examines the tissue and determines the type, subtype, and grade of the blood cancer. [Link to: /medical-malpractice/pathology-errors]
• Imaging: CT scan or PET scan to determine the extent of disease. [Link to: /radiology-errors/pet-scan-nuclear-medicine]

Common Ways Leukemia and Lymphoma Are Misdiagnosed

Blood cancer misdiagnosis can occur at multiple points:

• Failure to investigate abnormal CBC: An abnormal CBC (elevated white blood cell count, abnormal cells, low platelets, anemia) is not investigated with further testing. The standard of care requires that an abnormal CBC prompt further evaluation, including peripheral blood smear and, if indicated, referral to a hematologist.
• Attributing symptoms to a less serious condition: Fatigue is attributed to stress or anemia. Fever is attributed to infection. Enlarged lymph nodes are attributed to a viral infection. Easy bruising is attributed to a minor injury.
• Failure to perform bone marrow biopsy: When leukemia is suspected, the standard of care requires bone marrow biopsy. Failure to perform this can delay diagnosis.
• Failure to perform lymph node biopsy: When an enlarged lymph node is persistent or suspicious, the standard of care requires biopsy -- ideally excisional biopsy. Failure to biopsy can delay diagnosis of lymphoma.
• Pathology errors: The pathologist or hematopathologist misinterprets the blood smear, bone marrow, or lymph node tissue -- missing cancer, misclassifying the type or subtype, or misidentifying the grade. Blood cancers are particularly complex, and pathology errors are a significant risk. [Link to: /medical-malpractice/pathology-errors]
• Failure to perform flow cytometry: Flow cytometry is essential for diagnosing and classifying blood cancers. Failure to perform flow cytometry can lead to misdiagnosis or incorrect classification.
• Failure to communicate or follow up: Abnormal CBC, blood smear, or biopsy results are not communicated or followed up. [Link to: /radiology-errors/communication-failures]
• Failure to refer to a hematologist/oncologist: When blood cancer is suspected, the standard of care requires referral to a specialist. Failure to refer can delay diagnosis and treatment.

The Impact of Delayed Blood Cancer Diagnosis

The impact of a delayed leukemia or lymphoma diagnosis can be devastating:

• Disease progression: Acute leukemias (AML, ALL) progress rapidly. Delay in diagnosis can allow the disease to progress to a more advanced stage, reducing the chance of remission and survival.
• More aggressive treatment: Delayed diagnosis may require more aggressive chemotherapy, stem cell transplant, or targeted therapy.
• Complications: Delayed treatment can lead to complications such as severe infections (due to low white blood cell count), bleeding (due to low platelets), and organ damage.
• Reduced survival: The most devastating consequence. For acute leukemias, early treatment is critical for survival. [Link to: /wrongful-death-lawyer]
• Physical and emotional toll: More aggressive treatment causes more side effects -- nausea, fatigue, hair loss, infertility, and emotional trauma.

When Misdiagnosis Constitutes Medical Malpractice

Leukemia or lymphoma misdiagnosis constitutes medical malpractice in New York when a healthcare provider deviated from the accepted standard of care and that deviation caused harm:

• The provider failed to investigate an abnormal CBC.
• The provider attributed symptoms (fatigue, fever, enlarged lymph nodes) to a less serious condition without appropriate workup.
• The provider failed to perform bone marrow biopsy or lymph node biopsy when indicated.
• The pathologist misinterpreted the blood smear, bone marrow, or tissue. [Link to: /medical-malpractice/pathology-errors]
• The provider failed to perform flow cytometry when indicated.
• The provider failed to communicate or follow up on abnormal results. [Link to: /radiology-errors/communication-failures]
• The provider failed to refer to a hematologist/oncologist when blood cancer was suspected.
• The deviation caused harm -- the disease progressed to a more advanced stage. [Link to: /delayed-diagnosis-lawyer/loss-of-chance]

Proving Your Blood Cancer Misdiagnosis Case

To prove a leukemia or lymphoma misdiagnosis case, we:

• Obtain medical records: Including primary care, hematology, pathology, and oncology records, CBC results, blood smear reports, bone marrow biopsy reports, flow cytometry reports, and imaging. [Link to: /resources/how-to-get-medical-records-for-a-lawsuit]
• Obtain pathology slides: We obtain the actual blood smear slides, bone marrow slides, and lymph node tissue slides for independent review by expert hematopathologists. [Link to: /medical-malpractice/pathology-errors]
• Engage expert review: We work with board-certified hematologists, hematopathologists, and oncologists who practice in New York.
• Establish the standard of care: We determine what the standard of care requires for blood cancer diagnosis.
• Establish causation: We prove that the misdiagnosis caused harm. [Link to: /delayed-diagnosis-lawyer/loss-of-chance]

Lavern's Law and Your Deadline to File

Blood cancer misdiagnosis cases in New York are subject to Lavern's Law:

• You have 2.5 years from the date you discovered (or should have discovered) the misdiagnosis to file a lawsuit.
• There is an absolute outer limit of 7 years from the date of the negligent act. [Link to: /misdiagnosis/laverns-law]
• If the misdiagnosis caused death, a wrongful death claim must be filed within 2 years of the date of death. [Link to: /wrongful-death/statute-of-limitations]

Compensation Available

A successful blood cancer misdiagnosis claim can provide compensation for:

• Medical expenses: Including past and future chemotherapy, stem cell transplant, targeted therapy, and medications
• Lost wages and lost earning capacity: For time missed from work and reduced ability to work
• Pain and suffering: NY has no cap on non-economic damages
• Reduced life expectancy: For the loss of years of life due to delayed diagnosis
• Wrongful death damages: If the misdiagnosis caused death [Link to: /wrongful-death/settlements]

Frequently Asked Questions

The value of a medical malpractice case in New York depends on several factors, including the severity of the injury, the strength of liability evidence, and the economic and non-economic damages involved. New York is one of the few states with no caps on medical malpractice damages, meaning there is no artificial limit on what you can recover. Below are typical settlement ranges based on injury severity.